Nyberg, W. A., Ark, J., To, A., Clouden, S., Reeder, G., Muldoon, J. J., … Eyquem, J. (2023). An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of Trac-CAR-T Cells in Immunocompetent Tumor Models. In MOLECULAR THERAPY (Vol. 31, pp. 538–538).

Nyberg, William A., Jonathan Ark, Angela To, Sylvanie Clouden, Gabriella Reeder, Joseph J. Muldoon, Jing-Yi Chung, et al. “An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of Trac-CAR-T Cells in Immunocompetent Tumor Models.” In MOLECULAR THERAPY, 31:538–538, 2023.

Nyberg WA, Ark J, To A, Clouden S, Reeder G, Muldoon JJ, et al. An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of Trac-CAR-T Cells in Immunocompetent Tumor Models. In: MOLECULAR THERAPY. 2023. p. 538–538.

Nyberg, William A., et al. “An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of Trac-CAR-T Cells in Immunocompetent Tumor Models.” MOLECULAR THERAPY, vol. 31, no. 4, 2023, pp. 538–538.

Nyberg WA, Ark J, To A, Clouden S, Reeder G, Muldoon JJ, Chung J-Y, Xie W, Allain V, Steinhart Z, Chang C, Talbot A, Rosales A, Kim S, Havlik P, Pimentel H, Asokan A, Eyquem J. An Evolved AAV Variant Enables Efficient Genetic Engineering of Murine T Cells and the Modeling of Trac-CAR-T Cells in Immunocompetent Tumor Models. MOLECULAR THERAPY. 2023. p. 538–538.